|
Nancy J. Wysenski was appointed Chief Operating Officer on September 6 2007. Ms. Wysenski a 30-year veteran of the health care industry most recently was the President of EMD Pharmaceuticals Inc. the U.S. subsidiary of Germany-based Merck KGaA. Prior to joining and co-founding EMD Ms. Wysenski was the Senior Vice President of Operations at NetGenics a venture capital-backed start-up company specializing in technologies for drug discovery. Earlier Ms. Wysenski held a number of positions of increasing scope and responsibility at Astra Merck culminating as Vice President of Sales. During her tenure at Astra Merck she also served on the company’s operating board. Prior to joining Astra Merck in 1990 she began her pharmaceutical industry career in 1984 at Merck Human Health where she held various positions of increasing responsibility. | 